About MedPharm
MedPharm is a company based in Guildford (United Kingdom) founded in 1998 by Marc Brown. The company has 108 employees as of December 31, 2021. MedPharm offers products and services including Formulation Development, In Vitro Testing, Commercial Production, and Analytical Methods. MedPharm operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Guildford, United Kingdom
- Employees 108 as on 31 Dec, 2021
- Founders Marc Brown
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medpharm Limited
- Date of Incorporation 07 Jun, 1999
- Jurisdiction GUILDFORD, SURREY
-
Annual Revenue
$26.7 M (USD)9as on Dec 31, 2021
-
Net Profit
-$154.57 K (USD)-118as on Dec 31, 2021
-
EBITDA
$82.81 K (USD)-92as on Dec 31, 2021
-
Latest Funding Round
Not available
- Investors
-
Employee Count
108
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedPharm
MedPharm offers a comprehensive portfolio of products and services, including Formulation Development, In Vitro Testing, Commercial Production, and Analytical Methods.
Service for creating and testing pharmaceutical formulations.
Testing methods to evaluate drug efficacy and safety.
Production of topical drugs for market supply.
Development of methods for drug analysis and bioequivalence.
Funding Insights of MedPharm
Investors in MedPharm
MedPharm has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked |
Investor details for MedPharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedPharm
Investment portfolio details for MedPharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedPharm
Detailed financials for MedPharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medpharm Comparisons
Peer comparison for MedPharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedPharm
MedPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of MedPharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medpharm
Complete news archive for MedPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedPharm
MedPharm was founded in 1998 and raised its 1st funding round 20 years after it was founded.
MedPharm is headquartered in Guildford, United Kingdom.
As of Dec 31, 2021, the latest employee count at MedPharm is 108.
Annual revenue of MedPharm is $26.7M as on Dec 31, 2021.
MedPharm was founded in 1998 in Guildford, United Kingdom, within the pharmaceutical sector. Operations center on topical and inhaled drug delivery methods, including MedSpray for aerosol-based mucosal films, MedTherm for thermogenic transdermal systems, and AquaRMed for humectant-enhanced bioavailability. Services encompass process development, formulation, performance testing, and clinical supply manufacturing, with emphasis on API and formulation production.
MedPharm's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
MedPharm offers Formulation Development, In Vitro Testing, Commercial Production, and Analytical Methods.
MedPharm has 1 investor. Key investors include Ampersand Capital Partners.